Medical professionals need to suggest sufferers to halt usage of all phosphodiesterase kind five (PDE5) inhibitors, including LEVITRA, and find professional medical consideration within the celebration of unexpected loss of eyesight in one or the two eyes. Such an party may be a indicator of nonarteritic anterior ischemic optic neuropathy (NAION),